Morgan’s Stocks 2026: Halftime Review Hits Key Lanes
At midyear 2026, JPMorgan’s top three overweight picks show a split: one stock has cleared its upside target, while t...
When emergencies hit, knowing where to find funds helps you avoid debt. This guide highlights fast sources to cover sudden expenses while keeping your budget intact.
16,313 articlesAt midyear 2026, JPMorgan’s top three overweight picks show a split: one stock has cleared its upside target, while t...
A sharp pullback in the IGV ETF puts a spotlight on Oracle’s ability to generate free cash flow amid AI investments. ...
Lilly is backing Absci with a $40 million investment as Absci advances ABS-201, a next-gen injectable targeting hair ...
Rocket Lab is pursuing a bold $8 billion strategy to merge rocket launches, satellites, and data services. Learn what...
The michael burry bear case returns to the AI chip story as depreciation gaps collide with decade-long financing, thr...
The June jobs report shows tepid hiring even as unemployment falls, highlighting mixed signals for households and mar...
Bloom Energy has drawn big investor attention after a dramatic rally. This guide breaks down what the company does, w...
Johnson & Johnson and Eli Lilly reported contrasting Q1 2026 results, pitting a durable, dividend-focused giant again...
Revolution Medicines has surged in 2026, with revolution medicines nearly 140% year-to-date gains drawing investor at...
SanDisk surged roughly 3,700% in a year, but a broad market pullback and profit-taking have funds trimming positions ...
If you want durable dividend income that lasts for decades, focus on cash-flow, contracts, and disciplined payouts. T...
As defense budgets surge in 2026, SHLD and XAR offer two distinct routes to ride the rearmament boom: a global tech t...